| |
LONDON, June 11, 2008-The European Medicines instrumentality (EMEA) has recommended updating the result intelligence for epoetin-containing medicines with a new threat for their use in cancer patients stating that blood transfusion shuold be the preferred method of correcting anaemia in patients pain cancer.
Epoetin-containing medicines are indicated in patients with persistent achat cialis non-starter and for the treatment of anaemia in symptomatic patients with non-myeloid growthsz receiving chemotherapy. The power痴 council for sanative Products for Possibly manlikme Use (CHMP) had noticeed new materials from studies that showed an increased endanger of sarcoma achat viagra generique development, venous thromboembolism and shorter all-inclusive survival in cancer patients who cleard epoetins compared to patients whl did not admit them. Following this periodical, the CHMP concluded, at its June 2008 union, that the improves of epketins persist acheter cialis surpass their hazards in the approved indications. be that as it may, in cancer patients with a reasonably lengthy existence-expectancy, the improve of using epoetins does not surpassthe hazard acheter cialis
sarcoma movement forward and shorter all-inclusive survival and consequently the board concluded that in these patients anaemia should be corrected with blood transfusionjs.
|
|
![[NEW]](./image/new_icon.gif){kind=icon}
FagacacyNig
- 08/7/4(金) 2:39 -
![[添付]](./file/070301.jpg){kind=small}
![[添付]](./file/red.jpg){kind=small}